The vitamin B5/coenzyme A axis: A target for immunomodulation?
Level 5 - mechanism / opinion, no new human data
Narrative review with mechanism-based reasoning and no original human data
PubMed 37482959 · doi:10.1002/eji.202350435
What was done
This narrative review synthesizes literature on the vitamin B5 (pantothenate) and coenzyme A (CoA) metabolic axis. It outlines pathways regulating vitamin B5 availability and discusses their roles in modulating Th17-mediated inflammation, CD8-dependent anti-tumor immunity, and tissue repair in chronic inflammatory or degenerative diseases.
What was found
The abstract reports no numerical findings or empirical data. It describes the theoretical and mechanistic roles of CoA in cellular energy production, lipid metabolism, and immune cell proliferation and differentiation.
Why it matters
It frames the vitamin B5/CoA metabolic pathway as a potential target for therapeutic immunomodulation across autoimmune conditions, oncology, and chronic inflammatory diseases.
Limits
This is a narrative review with no primary empirical data or systematic search methodology presented in the abstract. Claims rely on mechanistic extrapolation without clinical trial validation.
Cited by
- supports Pantothenic acid is a biochemical precursor used by the body to make coenzyme A.